| pubmed-article:18704389 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C0162791 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C0815017 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C1510802 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C0521942 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C0038951 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C0278329 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C1578536 | lld:lifeskim |
| pubmed-article:18704389 | lifeskim:mentions | umls-concept:C0038995 | lld:lifeskim |
| pubmed-article:18704389 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:18704389 | pubmed:dateCreated | 2008-11-26 | lld:pubmed |
| pubmed-article:18704389 | pubmed:abstractText | Angiotensin receptor blockers (ARBs) offer a new treatment alternative for patients with hypertension and heart failure. Due to comparatively high prices, most guidelines suggest ARBs be restricted to patients intolerant to angiotensin-converting enzyme inhibitors (ACEi). We analysed the prescribing patterns of ARBs in Sweden by combining prescription register data with patient self-reported data. | lld:pubmed |
| pubmed-article:18704389 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18704389 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18704389 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18704389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18704389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18704389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18704389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18704389 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18704389 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18704389 | pubmed:issn | 1432-1041 | lld:pubmed |
| pubmed-article:18704389 | pubmed:author | pubmed-author:GranathFredri... | lld:pubmed |
| pubmed-article:18704389 | pubmed:author | pubmed-author:BerlinAnitaA | lld:pubmed |
| pubmed-article:18704389 | pubmed:author | pubmed-author:WettermarkBjö... | lld:pubmed |
| pubmed-article:18704389 | pubmed:author | pubmed-author:FriskPiaP | lld:pubmed |
| pubmed-article:18704389 | pubmed:author | pubmed-author:MellgrenTor-O... | lld:pubmed |
| pubmed-article:18704389 | pubmed:author | pubmed-author:HedbergNiklas... | lld:pubmed |
| pubmed-article:18704389 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18704389 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:18704389 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18704389 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18704389 | pubmed:pagination | 1223-9 | lld:pubmed |
| pubmed-article:18704389 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:meshHeading | pubmed-meshheading:18704389... | lld:pubmed |
| pubmed-article:18704389 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18704389 | pubmed:articleTitle | Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines. | lld:pubmed |
| pubmed-article:18704389 | pubmed:affiliation | National Corporation of Swedish Pharmacies (Apoteket AB), SE-118 81, Stockholm, Sweden. pia.frisk@apoteket.se | lld:pubmed |
| pubmed-article:18704389 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18704389 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
